Find out what Mozobil could do for you

Mozobil is approved by the FDA to be used in combination with another
agent (granulocyte‑colony stimulating factor (G-CSF) to
mobilize hematopoietic stem cells to the peripheral blood for collection
and subsequent autologous transplantation in patients living with
non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM).

Learn how Mozobil could help

Supporting you through stem cell mobilization

Our passion is to facilitate access and provide support to patients. Explore available resources, including the CareASSIST Patient Support Program.

Explore Resources